Navigation Links
Relapse in Risk Management System Claims the Life of Robertson

This report mainly brings to the notice of the common man that how official failings led to a man being bludgeoned to death by a psychiatric patient// with a history of violence. Stuart Robertson was killed by James Smith, who was on conditional discharge from Leverndale Hospital in Glasgow, in October 2004. This report mainly gives us an insight of how there was no systematic approach to risk assessment.

There was a failure to respond adequately to clear signs that Smith's mental illness had relapsed while he was in the care of community-based mental health services. This report was by the Mental Welfare Commission for Scotland. It asks for a series of changes to be implemented by the Scottish Executive, NHS Greater Glasgow and social work chiefs in Glasgow. Smith, 46, had suffered mental problems since 1991. He was jailed for life in Glasgow in November after he admitted the homicide of Mr Robertson.

He had killed Mr Robertson, who also had a history of mental illness, by bludgeoning him to death with a hammer in Pollok Park, Glasgow. The report said that Smith's condition had relapsed in the summer of 2004 but there was no systematic approach to risk assessment in his care and supervision, and an inadequate focus by some of those involved in his care. There was no satisfactory strategy planned to deal with any relapse in his illness.

In the months before the killing he showed signs of relapse but was not recalled to hospital. The Executive, NHS Greater Glasgow and Glasgow City Council acknowledged it had identified weaknesses as the basic risk management was not proper. The deputy health minister, Lewis Macdonald, said that all steps to address the deficiencies identified are being done and the public need not worry about it.


'"/>




Page: 1

Related medicine news :

1. Medications to Prevent Relapse to Cocaine Use
2. Alcoholism Drug Fails To Prevent Drinking Relapses
3. Treatment For Prostate Cancer Relapse Linked To Marital Status
4. New Drug More Effective than Tamoxifen in Preventing Breast Cancer Relapse
5. Femara: The Wonder Drug to Prevent Relapse of Breast Cancer.
6. Rogue Mammary Stem Cells Could Hold Key To Breast Cancer Relapse
7. Hepatitis B Relapse In Cancer Chemotherapy Can Be Avoided By Antiviral Drug
8. Leftover Cancer Cells May Dictate Breast Cancer Relapse
9. Kids are More Prone to Tonsillitis Relapse
10. Colon Cancer Relapse Mainly Caused by Stem Cells
11. ALL Relapses in Most Children After Treatment
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/28/2017)... ... ... Intellitec Solutions announced the publication of a case study ... solution that integrates to their PointClickCare EHR software package. With the guidance of ... now has the capability to achieve its goal for a comprehensive EHR solution, ...
(Date:4/28/2017)... ... April 28, 2017 , ... Semrock’s highly popular SearchLight ... online modeling resource for fluorescence microscopists and optical system designers, enabling The Right ... years spanning the globe, SearchLight has become a tremendously popular tool for the ...
(Date:4/27/2017)... (PRWEB) , ... April 27, 2017 , ... Healthcare companies ... But they will rapidly reject an outdated healthcare executive resume. , “If you’re a ... at your executive resume and wondering if it’s as ready as you are for ...
(Date:4/27/2017)... ... April 27, 2017 , ... SyncDog, ... sponsorship at MobileIron Live! 2017 in Santa Clara, California. Each year, ... educational approach to helping organizations maximize the benefits of mobility in their operations ...
(Date:4/27/2017)... ... April 27, 2017 , ... Plastic Surgery Associates is excited to ... to present at the upcoming Aesthetic Meeting. Held in San Diego, at the San ... and Canales will lend their expertise to the Premier Global Hot Topics session, speaking ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will ... at the Sheraton Hotel in Toronto, Ontario . ... Company is scheduled to present on Tuesday, May 2 at 10:00 ... of the Board, Tony Holler will also attend the ... For more details about ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... BOSTON , April 19, 2017  New research provides ... with advanced Parkinson,s, according to a study released today that ... 69th Annual Meeting in Boston , ... comes to the treatment of Parkinson,s disease, the oral drug ... of life and longevity. But as the disease progresses, the ...
Breaking Medicine Technology: